Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice (Q30394323)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 29, 2010

Language	Label	Description	Also known as
English	Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice	scientific article published on September 29, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6

object named as

Ling Chen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20883733

23 July 2024

author name string

Xiangjing Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Weixu Meng

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Zhenyuan Dong

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Weiqi Pan

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Caijun Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0168170210003503?httpAccept=text/xml

1 reference

10.1016/J.VIRUSRES.2010.09.014

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

23 July 2024

https://api.elsevier.com/content/article/PII:S0168170210003503?httpAccept=text/plain

1 reference

10.1016/J.VIRUSRES.2010.09.014

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

23 July 2024

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

155

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

156-162

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

A pandemic warning?

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Human infection with highly pathogenic H5N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Eight-plasmid system for rapid generation of influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

DNA Immunization for Influenza Virus: Studies Using Hemagglutinin‐ and Nucleoprotein‐Expressing DNAs

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Genetic adjuvants for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Scientific barriers to developing vaccines against avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Probable person-to-person transmission of avian influenza A (H5N1)

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://api.crossref.org/works/10.1016/J.VIRUSRES.2010.09.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIRUSRES.2010.09.014

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30394323&oldid=2211144815"